Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials

Although pCR was correlated with OS, no evidence of individual-level surrogacy with OS was demonstrated, making it inappropriate to consider pCR as a surrogate endpoint for OS in resectable oesophageal cancer.

Authors

Institutions

Publication Details

Journal
British journal of surgery
Published
2025-05-31
DOI
https://doi.org/10.1093/bjs/znaf131
Citations
7
Primary Topic
Esophageal Cancer Research and Treatment
Type
article
Field-Weighted Citation Impact
14.04
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials

Thomas Ruhstaller, Yasunori Sato, Guillaume Piessen, Bianca Mostert et al.
7 citations
British journal of surgery
Esophageal Cancer Research and Treatment
14.04
article

Evaluation of pathological complete response as a surrogate endpoint for overall survival in resectable oesophageal cancer: integrated analysis of individual patient data from phase III trials

Thomas Ruhstaller, Yasunori Sato, Guillaume Piessen, Bianca Mostert, Kengo Nagashima, Charlène J. van der Zijden, Bas P. L. Wijnhoven, Shaoyuan Zhang, Thomas Aparicio, Jun Okui, Fredrik Klevebro, Hiroya Takeuchi, Satoru Matsuda, Peter Thuss‐Patience, Magnus Nilsson, Ken Kato, Lijie Tan, Hirofumi Kawakubo, Takahiro Tsushima, Yuko Kitagawa
article en
7 citations

Abstract

Although pCR was correlated with OS, no evidence of individual-level surrogacy with OS was demonstrated, making it inappropriate to consider pCR as a surrogate endpoint for OS in resectable oesophageal cancer.

British journal of surgeryVol. 112(6)
Karolinska University Hospital (SE), Inserm (FR), Sun Yat-sen University (CN), University of Basel (CH), Keio University (JP), Université Paris Cité (FR), Université de Lille (FR), Fudan University (CN), Erasmus MC (NL), Karolinska Institutet (SE), Hamamatsu University School of Medicine (JP), Shizuoka Cancer Center (JP), National Cancer Center (US), Keio University Hospital (JP), Zhongshan Hospital (CN), The First Affiliated Hospital, Sun Yat-sen University (CN), Hôpital Saint-Louis (FR), Swiss Group For Clinical Cancer Research (CH), Erasmus MC Cancer Institute (NL), CANTHER - Hétérogénéité, Plasticité et Résistance aux Thérapies des Cancers (FR), Charité - Universitätsmedizin Berlin (DE)
Openalex Percentile: Top 1%
Esophageal Cancer Research and Treatment
14.04
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.